Pacira Pharmaceuticals, Inc. to Be Added to NASDAQ Biotechnology Index
News | 22 May 2012
PARSIPPANY, NJ--(BUSINESS WIRE)--May 21, 2012 - Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index
Click on the link to read the full article at PharmaLive.com (press release)
(This link will open in a new window)
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
